Advertisement
Screener

HERON THERAPEUTICS, INC. /DE/ (HRTX) Form D

HERON THERAPEUTICS, INC. /DE/ Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2012-08-10: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2012-07-30; Total offering amount $53,549,999.
  • 2009-11-05: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; (i) Common Stock and (ii) Warrants to purchase shares of Common Stock (including the shares of Common Stock issuable upon exercise of the Warrants).; Date of first sale 2009-10-22; Total offering amount $16,642,811.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2012-08-10Rule 506Equity2012-07-30$53,549,999$53,549,999$021
2009-11-05Rule 506Equity; OptionToAcquire; (i) Common Stock and (ii) Warrants to purchase shares of Common Stock (including the shares of Common Stock issuable upon exercise of the Warrants).2009-10-22$16,642,811$8,142,817$8,499,9947

Similar stocks

Stock NameCountryMarket CapPE Ratio
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
Xilio Therapeutics, Inc. (XLO)United States$0.052B
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
TALPHERA, INC. (TLPH)United States$0.060B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Lite Strategy, Inc. (LITS)United States$0.049B